2-71349889-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000264447.9(ZNF638):āc.935A>Gā(p.Asn312Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,614,242 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000264447.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF638 | NM_014497.5 | c.935A>G | p.Asn312Ser | missense_variant | 2/28 | ENST00000264447.9 | NP_055312.2 | |
ZNF638 | NM_001014972.3 | c.935A>G | p.Asn312Ser | missense_variant | 2/28 | NP_001014972.1 | ||
ZNF638 | NM_001252612.2 | c.935A>G | p.Asn312Ser | missense_variant | 2/28 | NP_001239541.1 | ||
ZNF638 | NM_001252613.2 | c.935A>G | p.Asn312Ser | missense_variant | 2/28 | NP_001239542.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF638 | ENST00000264447.9 | c.935A>G | p.Asn312Ser | missense_variant | 2/28 | 1 | NM_014497.5 | ENSP00000264447.4 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152248Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251414Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135862
GnomAD4 exome AF: 0.000234 AC: 342AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.000235 AC XY: 171AN XY: 727238
GnomAD4 genome AF: 0.0000984 AC: 15AN: 152366Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74510
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at